Department of Pharmacy, Sarhad University of Science and Information Technology, Peshawar, Khyber Pakhtunkhwa, Pakistan.
Faculty of Biological Sciences, Department of Biochemistry, Quaid-i-Azam University, Islamabad, Pakistan.
Biomed Pharmacother. 2018 Apr;100:461-466. doi: 10.1016/j.biopha.2018.01.008. Epub 2018 Feb 15.
The demand for natural medicines has increased because of their limited adverse effects. The aim of study is to explore the antidiabetic potential of isolated steroidal alkaloid from Sarcococca saligna in streptozotocin induced diabetic rats. To determine the antidiabetic activity of steroidal alkaloids, diabetes was induced in rats by injecting streptozotocin intraperitoneally at a dose of 40 mg/Kg. After a week of STZ injection the treatment were started and the 8th day was considered as the 1st day of treatment and up to four weeks the rats were treated with steroidal alkaloids. Animals were divided into five groups, group 1 considered as a control group by receiving normal saline (1 ml/Kg) twice daily and group 2, 3, 4 were treated with active compound sarcovagine-D, saracodine and holaphylline at the dose of 5 mg/Kg subcutaneously twice a day while group 5 was treated with a standard drug glibenclamide at a dose of 1 mg/Kg/day. The result showed that treated group 2 and 4 reduced the glucose level in blood significantly while group 3 showed moderate glucose reduction. The fructosamine level reduced significantly in treating group 4 from the 2nd week of treatment while group 2 and 3 decreased the level significantly in week 4 in diabetic rats. The treated groups showed gradual decreases the glucose level in 1st and 2nd week of oral glucose tolerance test compared to control group. The group receiving holaphylline (4) and sarcovagine-D (2) showed good improvements in blood lipids while the effect of compound on body weight showed less significant improvement. The present study concluded that steroid alkaloids from isolated Sarcococca saligna possess hypoglycemic effect and improve others diabetes associated complications. Together these finding further research is needed using a range of doses to explore the other possible beneficial effects in diabetes mellitus and its molecular mechanism.
由于其不良反应有限,对天然药物的需求有所增加。本研究旨在探索从南非钩果中分离得到的甾体生物碱对链脲佐菌素诱导的糖尿病大鼠的降血糖作用。为了确定甾体生物碱的降血糖活性,通过腹腔内注射链脲佐菌素(STZ)40mg/Kg 的剂量诱导大鼠糖尿病。在 STZ 注射后一周开始治疗,第 8 天被认为是治疗的第 1 天,持续 4 周用甾体生物碱治疗大鼠。动物分为五组,第 1 组作为对照组,每天两次接受生理盐水(1ml/Kg),第 2、3、4 组每天两次皮下给予活性化合物 sarcovagine-D、saracodine 和 holaphylline 治疗,剂量为 5mg/Kg,第 5 组每天一次给予标准药物格列本脲(glibenclamide)治疗,剂量为 1mg/Kg。结果表明,治疗组 2 和 4 显著降低了血糖水平,而治疗组 3 显示出中等程度的血糖降低。从治疗的第 2 周开始,治疗组 4 的果糖胺水平显著降低,而治疗组 2 和 3 在糖尿病大鼠的第 4 周显著降低了果糖胺水平。与对照组相比,治疗组在口服葡萄糖耐量试验的第 1 和第 2 周血糖水平逐渐下降。接受 holaphylline(4)和 sarcovagine-D(2)治疗的组显示出良好的血脂改善,而化合物对体重的影响显示出较小的改善。本研究得出结论,从南非钩果中分离得到的甾体生物碱具有降血糖作用,并改善其他糖尿病相关并发症。这些发现表明,需要进一步研究使用一系列剂量来探索糖尿病及其分子机制的其他可能有益作用。